Patients with chronic inflammatory rheumatic conditions such as systemic lupus
erythematosus (SLE), rheumatoid arthritis (RA), spondyloarthritis (psoriatic arthritis and …

Patients with rheumatoid arthritis (RA) suffer significantly increased cardiovascular (CV)
morbidity and mortality, when compared with the general population. Both traditional CV risk …

Rheumatoid arthritis (RA) is the most common inflammatory arthritis disease with a
worldwide prevalence of 1–3%. RA patients are at higher risk of atherosclerosis than their …

Chronic inflammatory rheumatic diseases (IRD), including rheumatoid arthritis, ankylosing
spondylitis, and psoriatic arthritis, are prevalent conditions worldwide, with a considerable …

Cardiovascular manifestations of rheumatic diseases have been thoroughly examined over
the past decades. It has been established that all structures of the heart can be affected due …

Objectives To elucidate the risk and temporal relationship of cardiovascular (CV)
comorbidities in rheumatic diseases. Methods Patients in the FinnGen study diagnosed …

Patients with rheumatic disorders have an increased risk of cardiovascular disease (CVD).
This excess co-morbidity is not fully explained by traditional risk factors. Disease severity is a …

Rheumatoid arthritis (RA) is associated with increased morbidity and mortality due to
cardiovascular disease (CVD), mostly accelerated atherosclerotic CVD, and there is …

The risk of cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA) is higher
than that in patients without RA, and it is even higher than that in patients with diabetes …

Cardiovascular disease is recognized as a significant cause of premature mortality in
patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) …